Priyanka Dayal Mccluskey

The company that controls Steward Health Care's hospital properties in Massachusetts has rejected Gov. Maura Healey's proposal to save St.

If approved, the deal will cover hospital operations and real estate for St. Anne's Hospital in Fall River and Morton Hospital in Taunton. The announcement is the first tangible sign that months of negotiations to determine the future of Steward's Massachusetts hospitals are bearing fruit.

At a hearing in U.S. Bankruptcy Court in Houston, Judge Christopher Lopez said his final decision would come later in the day. “I’m really leaning towards approving the sale,” Lopez said. “This is the best deal that’s on the table, and that’s saying a lot. There’s been an extensive process.”

U.S. Senators Ed Markey and Elizabeth Warren on Thursday pledged action against Steward Health Care’s chief executive for flouting a Congressional subpoena, saying they would move to hold him in contempt of Congress.

U.S. Senators on Thursday called Steward Health Care's CEO the poster child for corporate greed in health care and vowed to vote next week to hold him in civil and criminal contempt.

U.S. Sen. Ed Markey joins Radio Boston on the heels of a Senate committee hearing on bankrupt Steward Health to share his thoughts on the hospital's chain's collapse.

A U.S. Senate committee voted Thursday to hold Steward Health Care CEO Ralph de la Torre in civil and criminal contempt after he refused to testify publicly about his company's bankruptcy. The two votes were unanimous, 20 to zero, with just one member abstaining.

Dr. Sarju Ganatra, a cardiologist at Lahey Hospital and Medical Center, has noticed a trend among the patients who arrive at the hospital with unexpected heart problems: A disproportionate number of them are South Asian.

To detect warning signs of heart problems in high-risk patients, some hospitals and health centers use remote blood pressure monitoring. Patients take their readings at home on devices that send their data to medical providers. And MassHealth is now picking up some of these treatment costs.

Insurers said one major driver of higher premiums is the growing popularity of a relatively new class of injectable drugs to manage diabetes and weight loss.